15 completed, 4 unknown, 3 terminated, 1 recruiting. 23 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 23 | Completed 15, Unknown 4, Terminated 3, Recruiting 1 |
Follow Growth Hormone Deficiency: new trials by email Literature Review of Growth Hormone Deficiency trials Research Report on Growth Hormone Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of GH and Lirglutide on AgRP growth hormone and lirglutide, growth hormone, liraglutide - Healthy, Growth Hormone Deficiency | Phase 4 | Recruiting | Columbia University | 40 | 2023-05-01 | 2026-03-04 |
| Body Composition and Adipose Tissue in HIV Tesamorelin - HIV Lipodystrophy Syndrome, Growth Hormone Deficiency | Phase 4 | Terminated | Columbia University | 6 | 2018-02-07 | 2026-05-19 |
| Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. Somatropin - Short Stature, Idiopathic, Infant, Small for Gestational Age | Phase 4 | Completed | LG Life Sciences | 116 | 2016-08-11 | 2019-01-03 |
| A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency Somatropin - Growth Hormone Deficiency | Phase 4 | Completed | Genentech, Inc. | 82 | 2015-03-31 | 2019-01-08 |
| Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency PEG-somatropin - Growth Hormone Deficiency | Phase 4 | Unknown | Changchun GeneScience Pharmaceutical Co., Ltd. | 600 | 2015-01-01 | 2017-06-16 |
| Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency PEG-somatropin - Growth Hormone Deficiency | Phase 4 | Unknown | Changchun GeneScience Pharmaceutical Co., Ltd. | 900 | 2015-01-01 | 2017-08-15 |
| Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I) PEG-somatropin - Growth Hormone Deficiency | Phase 4 | Unknown | Changchun GeneScience Pharmaceutical Co., Ltd. | 600 | 2014-12-01 | 2017-06-16 |
| Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency PEG-somatropin - Growth Hormone Deficiency | Phase 4 | Unknown | Changchun GeneScience Pharmaceutical Co., Ltd. | 900 | 2014-11-01 | 2017-06-14 |
| GH and Cardiovascular Risk Factors Change in daily dosage of Growth Hormone - Growth Hormone Deficiency, Cardiovascular Diseases | Phase 4 | Completed | Amsterdam UMC, location VUmc | 32 | 2013-05-01 | 2014-05-07 |
| Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.) sustained-release recombinant human GH (SR-rhGH) - Growth Hormone Deficiency | Phase 4 | Completed | LG Life Sciences | 132 | 2009-12-01 | 2012-10-05 |
| Comparison of a Needle-free Injection Method With a Needle-syringe Injection Method T-jet® containing TevTropin®, TevTropin® needle-syringe injection method - Growth Hormone Deficiency | Phase 4 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 52 | 2009-09-01 | 2011-07-25 |
| Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome? Growth hormone (Genotonorm® or Omnitrope®), DEXA, blood tests, H.G.P.O, osseous age., biopsy - Prader-Willi Syndrome, Growth Hormone Deficiency | Phase 4 | Completed | University Hospital, Toulouse | 111 | 2009-01-01 | 2021-09-24 |
| Easypod United States User Trial easypod - Growth Hormone Deficiency | Phase 4 | Completed | EMD Serono | 42 | 2008-03-01 | 2015-05-15 |
| Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury Genotropin, Placebo - Brain Injuries, Growth Hormone Deficiency | Phase 4 | Terminated | Pfizer | 10 | 2008-03-01 | 2010-06-02 |
| Adult Growth Hormone Deficiency and Cardiovascular Risk Blood draws, growth hormone releasing hormone (GHRH) & arginine, Carotid ultrasound - Growth Hormone Deficiency | Phase 4 | Terminated | Columbia University | 7 | 2007-02-01 | 2022-11-16 |
| Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN® Saizen - Growth Hormone Deficiency, Turner Syndrome | Phase 4 | Completed | Merck KGaA, Darmstadt, Germany | 318 | 2005-05-31 | 2018-06-26 |
| Growth Hormone and Endothelial Function in Children growth hormone - Growth Hormone Deficiency, Panhypopituitarism | Phase 4 | Completed | Ohio State University | 9 | 2005-01-01 | 2018-05-30 |
| A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood Nutropin AQ - Kidney Failure, Chronic, Growth Hormone Deficiency | Phase 4 | Completed | Oregon Health and Science University | 17 | 2005-01-01 | 2011-10-26 |
| Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia Nutropin AQ - Growth Hormone Deficiency, Septo-Optic Dysplasia | Phase 4 | Completed | Children's Hospital Los Angeles | 20 | 2004-12-01 | 2015-04-01 |
| Growth Hormone and Glucose Metabolism recombinant human Growth Hormone (Genotropin® ) - Growth Hormone Deficiency | Phase 4 | Completed | Charite University, Berlin, Germany | 6 | 2003-11-01 | 2009-06-30 |
Showing 20 of 23. Sign in to see all of them.
Dwarfism, Pituitary (23) · Dwarfism (4) · Brain Injuries, Traumatic (2) · Kidney Failure, Chronic (2) · Turner Syndrome (2) · Brain Injuries (1) · Cardiovascular Diseases (1) · Combined Pituitary Hormone Deficiency (1) · HIV-Associated Lipodystrophy Syndrome (1) · Hypopituitarism (1) · Metabolic Syndrome (1) · Motor Activity (1) · Optic Nerve Hypoplasia (1) · Prader-Willi Syndrome (1) · Septo-Optic Dysplasia (1)
Bone Diseases (23) · Bone Diseases, Developmental (23) · Bone Diseases, Endocrine (23) · Brain Diseases (23) · Central Nervous System Diseases (23) · Endocrine System Diseases (23) · Hypothalamic Diseases (23) · Musculoskeletal Diseases (23) · Nervous System Diseases (23) · Pituitary Diseases (23) · Hypopituitarism (22) · Dwarfism (19) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Genetic Diseases, Inborn (7) · Congenital Abnormalities (4)
Human Growth Hormone (8) · Growth Hormone (7) · Blood Specimen Collection (2) · Absorptiometry, Photon (1) · Arginine (1) · Biopsy (1) · Growth Hormone-Releasing Hormone (1) · Hematologic Tests (1) · Liraglutide (1) · X-Rays (1) · tesamorelin (1)
Changchun GeneScience Pharmaceutical Co., Ltd. (4) · Columbia University (3) · LG Life Sciences (2) · Merck KGaA, Darmstadt, Germany (2) · Pfizer (2) · Amsterdam UMC, location VUmc (1) · Charite University, Berlin, Germany (1) · Children's Hospital Los Angeles (1) · EMD Serono (1) · Genentech, Inc. (1) · Ohio State University (1) · Oregon Health and Science University (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1) · The University of Texas Medical Branch, Galveston (1) · University Hospital, Toulouse (1)
United States (9) · China (4) · France (4) · Germany (2) · Italy (2) · Netherlands (2) · Spain (2) · Sweden (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Austria (1) · Canada (1) · Norway (1) · Russia (1)
Amira Y Al-Uzri, M.D. (1) · Ayman M Arafat, Dr.med. (1) · Chunxiu Gong (1) · Feihong Luo, Doctor (1) · John C Ausiello, MD (1) · Junfen Fu, PhD (1) · Madeleine L. Drent, MD PhD (1) · Mark Borchert, MD (1) · Mitchell Geffner, MD (1) · Pamela U. Freda, MD (1)
PMID 20372873, PMID 23567489, PMID 24013497, PMID 24406482, PMID 24916642, PMID 26340968, PMID 29618660, PMID 29980224, PMID 31908426, PMID 33633687, PMID 34040195, PMID 34045667, PMID 34899612, PMID 35945517, PMID 36034802, PMID 38561465
R01DK110771 (1)